Janssen Search
Search results
Neil Davie, Ph.D.
NEIL DAVIE, Ph.D. HEAD, LATE DEVELOPMENT CARDIOVASCULAR, METABOLISM & PULMONARY HYPERTENSION Neil Davie, Ph.D. is the Head, Late Development, of Cardiovascular, Metabolism, & Pulmonary Hypertension (CVM & PH). He has extensive experience as a ...
Janssen Enters Worldwide Collaboration and License Agreement with Cellular Biomedicine Group to Develop Next Generation CAR-T Therapies
May 02, 2023 United States Investigational CD20-targeted CAR-Ts Enhance Janssen’s B-cell Malignancy Portfolio Agreement Deepens Janssen’s Leadership in Oncology and Hematology, and Accelerates Commitment to Delivering Transformational Cell Therapies ...
Michelle Kramer, M.D., M.P.H.
MICHELLE KRAMER, M.D., M.P.H. GLOBAL HEAD OF DEVELOPMENT Michelle Kramer, M.D., M.P.H. is the Global Head of Development for Neuroscience at Janssen Research & Development. With more than two decades of experience at Janssen and Johnson & Johnson, ...
Oncology Careers
Oncology Careers: What Kind of Mark Will You Make? Janssen’s Oncology organization fosters the passion within our people by developing their careers, creating a collaborative environment and unifying behind a common goal – to make a difference in the ...
Pamela Carroll, Ph.D.
Pamela Carroll, Ph.D. is Vice President of Oncology Scientific Innovation at Janssen Research & Development, LLC. She represents the Oncology Therapeutic Area in Johnson & Johnson Innovation, Boston and is responsible for leading partnerships and ...
Pamela Carroll, Ph.D.
Pamela Carroll, Ph.D. is Vice President of Oncology Scientific Innovation at Janssen Research & Development, LLC. She represents the Oncology Therapeutic Area in Johnson & Johnson Innovation, Boston and is responsible for leading partnerships and ...
Joseph Hedrick, Ph.D.
JOSEPH HEDRICK, PH.D. HEAD, TYPE 1 DIABETES VENTURE WORLD WITHOUT DISEASE ACCELERATOR As Head of the Type 1 Diabetes (T1D) Venture within the World Without Disease Accelerator (WWDA), Joe leads efforts utilizing the rapidly emerging science of immune ...
Dan Baker, M.D.
Dan Baker, M.D. joined the Janssen Pharmaceutical Companies of Johnson & Johnson through Centocor Research & Development in 2000 following an 18-year academic career at the University of Pennsylvania in Philadelphia, Pennsylvania. Since joining ...
Opening Vaccines Launch Facility speakers
Oct 24, 2018 Speakers Inspiring and engaging presentations and panal discussions will hightlight why it is important to "invest locally, to protect globally". View the complete program of the symposium. Moderator Guest speakers/panelists ...
ASCO GU 2022
Leadership Perspectives Welcome to the Janssen Oncology ASCO GU Virtual Newsroom At the Janssen Pharmaceutical Companies of Johnson & Johnson, we are driven by our vision to eliminate cancer. As we pursue this ambitious goal, we are pleased to share ...